Micah Young serves as the Executive Vice President and Chief Financial Officer at Masimo Corporation, a global medical technology company that develops and manufactures non-invasive patient monitoring technologies. In his role, Young is responsible for overseeing the financial operations and strategy of the company, ensuring its continued growth and profitability. He plays a critical role in guiding Masimo's financial decisions and works closely with the executive team to drive the company's mission of improving patient outcomes and reducing the cost of care. Prior to joining Masimo in 2017, Young held various senior financial positions at leading healthcare and technology companies. He spent over a decade at Abbott Laboratories, where he served as the Divisional CFO for the company's Diagnostics business, managing a multi-billion dollar global operation. During his tenure at Abbott, Young played a key role in driving the financial success of the Diagnostics division and implementing strategic initiatives to enhance profitability. Before Abbott, he worked at PricewaterhouseCoopers (PwC) as a Senior Manager in the firm's Transaction Services group, where he advised clients on mergers, acquisitions, and other corporate transactions. Young's extensive experience in finance and healthcare, combined with his strategic vision, have been instrumental in Masimo's growth and success. Under his leadership, the company has continued to expand its product portfolio and global presence, while maintaining a strong financial position. Young holds a Bachelor of Science degree in Accounting from the University of Illinois at Urbana-Champaign and is a Certified Public Accountant (CPA). His dedication to excellence and commitment to Masimo's mission have made him a valuable asset to the company and the healthcare industry as a whole.